Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00392704 · ClinicalTrials.gov registry record · Phase 2
Treatment of Head & Neck Cancer With Chemotherapy and Radiation
A Phase 2 study, sponsored by SCRI Development Innovations.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00392704: Completed Phase 2 study, sponsored by SCRI Development Innovations.
NCT00392704 is a Phase 2 study that has completed, run by SCRI Development Innovations. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00392704, a Phase 2 study, has completed, sponsored by SCRI Development Innovations.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Two new cancer treatment drugs called targeted therapies will be added to standard treatment for head and neck cancer to see if an improvement can be made in the effectiveness of treatment for this type of cancer. Treatment will include chemotherapy, radiation therapy and targeted therapy taken over a period of 4 months.
Primary Outcome
The percentage of patients estimated to be alive 2 years after beginning protocol treatment
Interventions
- DRUG Bevacizumab
- DRUG Paclitaxel
- RADIATION Radiation Therapy
- DRUG 5-FU
- DRUG Erlotinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
What the finished NCT00392704 record still lists
NCT00392704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 5 interventions - of which Bevacizumab is the first listed.
NCT00392704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00392704 about?
NCT00392704 is a clinical study titled "Treatment of Head & Neck Cancer With Chemotherapy and Radiation". Two new cancer treatment drugs called targeted therapies will be added to standard treatment for head and neck cancer to see if an improvement can be made in the effectiveness of treatment for this type of cancer. Treatment will include chemotherapy, radiation therapy and targeted therapy taken over...
What is the current status of trial NCT00392704?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-12. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00392704?
The interventions under investigation include: Bevacizumab (DRUG), Paclitaxel (DRUG), Radiation Therapy (RADIATION), 5-FU (DRUG), Erlotinib (DRUG).
Who is sponsoring clinical trial NCT00392704?
This trial is sponsored by SCRI Development Innovations, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00392704's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia